Date	Period	Revenue/Estimate	Earnings Call
--	2027/Q1	-- / 38.500B	--
--	2026/Q1	-- / 37.000B	--
Jul 11, 2024	2025/Q1	35.810B / 36.500B	--
Jan 11, 2024	2024/Q3	35.850B / --	--
Jul 13, 2023	2024/Q1	32.096B / 31.000B	--

DatePeriodRevenue/EstimateEarnings Call

--2027/Q1-- / 38.500B--

--2026/Q1-- / 37.000B--

Jul 11, 20242025/Q135.810B / 36.500B--

Jan 11, 20242024/Q335.850B / ----

Jul 13, 20232024/Q132.096B / 31.000B--

Unlock Free Earnings Estimates

Open Account

Hisamitsu Pharmaceutical Earnings Reports

Hisamitsu Pharmaceutical: Confirmation letter

Oct 11 02:12 ET

Hisamitsu Pharmaceutical: Semi-annual report - Period 123 (2024/03/01 - 2025/02/28)

Oct 11 02:08 ET

Hisamitsu Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending February 2025 [Japanese GAAP] (consolidated)

Oct 10 02:00 ET

Hisamitsu Pharmaceutical: Confirmatory letter.

Jul 12 02:12 ET

Symbol Price % Chg

Beauty Kadan Holdings